NPI: 1184176059 · WISCONSIN RAPIDS, WI 54494 · Specialist · NPI assigned 10/26/2016
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHIEF FINANCIAL OFFICER) |
| Parent Organization | ASPIRUS INC |
| NPI Enumeration Date | 10/26/2016 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,895 | $615K |
| 2019 | 21,697 | $622K |
| 2020 | 18,737 | $523K |
| 2021 | 24,278 | $688K |
| 2022 | 23,176 | $746K |
| 2023 | 21,801 | $720K |
| 2024 | 15,719 | $780K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 65,192 | 59,519 | $2.08M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18,589 | 17,068 | $982K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6,139 | 5,567 | $344K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,089 | 4,956 | $299K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,194 | 3,124 | $186K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,171 | 1,067 | $144K |
| 99307 | 3,428 | 3,201 | $111K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,314 | 1,285 | $77K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4,620 | 4,236 | $53K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,957 | 2,778 | $42K |
| 92551 | 3,031 | 2,948 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 721 | 683 | $34K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 242 | 235 | $33K |
| 90686 | 4,606 | 4,475 | $25K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2,435 | 2,332 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 837 | 778 | $19K |
| 99304 | 410 | 394 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,060 | 480 | $15K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 756 | 516 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 134 | 109 | $13K |
| 80053 | Comprehensive metabolic panel | 1,285 | 1,188 | $13K |
| 90670 | 3,016 | 2,885 | $12K | |
| 90677 | 531 | 504 | $12K | |
| 90647 | 1,616 | 1,547 | $11K | |
| 0002A | 280 | 277 | $10K | |
| 90723 | 1,327 | 1,271 | $10K | |
| 0001A | 263 | 258 | $9K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 111 | 98 | $7K |
| 90633 | 1,098 | 1,062 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 701 | 658 | $5K |
| 80061 | Lipid panel | 315 | 302 | $5K |
| 90681 | 708 | 681 | $4K | |
| 99173 | 229 | 225 | $4K | |
| 59025 | Fetal non-stress test | 138 | 93 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 13 | 12 | $3K |
| 99215 | Prolong outpt/office vis | 39 | 37 | $3K |
| 90651 | 465 | 457 | $3K | |
| 90656 | 164 | 164 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 274 | 257 | $2K |
| 0004A | 52 | 51 | $2K | |
| 90698 | 574 | 554 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 247 | 226 | $2K |
| 81001 | 508 | 481 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | 128 | 117 | $1K |
| 99152 | 51 | 50 | $1K | |
| 90734 | 240 | 238 | $1K | |
| 0012A | 29 | 28 | $995.20 | |
| 99460 | 14 | 12 | $985.63 | |
| 99188 | 78 | 77 | $973.17 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 30 | 29 | $963.56 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 43 | 29 | $904.99 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 12 | 12 | $877.44 |
| 99238 | Hospital discharge day management, 30 minutes or less | 26 | 24 | $845.31 |
| 87634 | 13 | 12 | $836.82 | |
| 90744 | 265 | 251 | $810.99 | |
| 99000 | 221 | 181 | $733.43 | |
| 90685 | 218 | 214 | $711.06 | |
| 90710 | 121 | 117 | $696.43 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 83 | 77 | $681.02 |
| 0064A | 17 | 17 | $650.24 | |
| 0011A | 39 | 38 | $649.16 | |
| 99383 | 12 | 12 | $644.35 | |
| 85027 | 92 | 90 | $594.71 | |
| 90696 | 44 | 42 | $282.45 | |
| 90715 | 73 | 72 | $239.38 | |
| 99442 | 12 | 12 | $233.76 | |
| 81025 | 29 | 28 | $225.23 | |
| 36415 | Collection of venous blood by venipuncture | 4,678 | 4,326 | $146.59 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 1,378 | 1,338 | $130.66 |
| 85018 | 43 | 40 | $97.85 | |
| 91300 | 54 | 54 | $0.09 | |
| 91301 | 20 | 19 | $0.02 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 119 | 119 | $0.00 |
| 90381 | 19 | 17 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 42 | 42 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 156 | 141 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 25 | 24 | $0.00 |